Toptal enhances Fortune 500 pharmaceutical company’s internal analytics tool.

A leading pharmaceutical company required improvements to its internal analytics tool. Toptal streamlined interfaces and added features for improved decision-making and operational efficiency.

Client

A global biopharmaceutical company developing medicines and vaccines across major therapeutic areas.

Employees

83,000+

Revenue

$55B

Industry

Healthcare and Life Sciences

Delivered Services

Get a free consultation now

Schedule a Call

Challenge

The company’s internal analytics tool had disjointed interfaces that hindered management decision-making and required a more cohesive system.

Solution

Interface Integration

Toptal conducted stakeholder interviews and replaced outdated screens with cohesive, user-friendly interfaces, significantly improving usability.

Feature Enhancement

Toptal integrated advanced features, including improved financial forecast visibility, a flexible admin panel, and advanced export capabilities.

Outcome

Unified Interfaces

Toptal’s redesigned and unified UX simplified and improved the company’s access to analytics, enhancing management’s ability to make informed decisions.

Improved Efficiency

The new features boosted operational efficiency, providing faster, easier-to-use decision-making tools and streamlining management processes.

Share

Get a free consultation now

Schedule a Call